BNTX
BioNTech SE
NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY
$101.57
-0.48% today
Updated 2026-04-29
Market cap
$25.69B
P/E ratio
—
P/S ratio
8.95x
EPS (TTM)
$-5.50
Dividend yield
—
52W range
$80 – $124
Volume
1.2M
BioNTech SE (BNTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-52.56M | $-58.18M | $-198.50M | $-13.50M | $889.70M | $13.58B | $5.37B | $207.70M | $438.00M |
| Capital expenditures | $57.74M | $67.85M | $71.10M | $85.40M | $154.00M | $363.30M | $705.50M | $452.30M | $168.19M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $5.91M | $7.64M | $30.20M | $32.10M | $93.90M | $108.60M | $51.40M | $100.90M | $106.20M |
| Free cash flow | $-110.30M | $-126.03M | $-269.60M | $-98.90M | $735.70M | $13.21B | $4.67B | $-244.60M | $269.81M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $484.30M | $0.00 | $0.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |